SHIRE BIOTECH UK HOLDINGS LIMITED

SHIRE BIOTECH UK HOLDINGS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameSHIRE BIOTECH UK HOLDINGS LIMITED
    Company StatusDissolved
    Legal FormPrivate limited company
    Company Number 10945403
    JurisdictionEngland/Wales
    Date of Creation
    Date of Cessation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of SHIRE BIOTECH UK HOLDINGS LIMITED?

    • Activities of other holding companies n.e.c. (64209) / Financial and insurance activities

    Where is SHIRE BIOTECH UK HOLDINGS LIMITED located?

    Registered Office Address
    1 Kingdom Street
    W2 6BD London
    United Kingdom
    Undeliverable Registered Office AddressNo

    What are the latest accounts for SHIRE BIOTECH UK HOLDINGS LIMITED?

    Last Accounts
    Last Accounts Made Up ToDec 31, 2020

    What are the latest filings for SHIRE BIOTECH UK HOLDINGS LIMITED?

    Filings
    DateDescriptionDocumentType

    Final Gazette dissolved via voluntary strike-off

    1 pagesGAZ2(A)

    First Gazette notice for voluntary strike-off

    1 pagesGAZ1(A)

    Application to strike the company off the register

    3 pagesDS01

    Confirmation statement made on Sep 04, 2022 with no updates

    3 pagesCS01

    Appointment of Peter Michael Grubin as a director on Mar 01, 2022

    2 pagesAP01

    Termination of appointment of Kentaro Shirahata as a director on Mar 01, 2022

    1 pagesTM01

    Full accounts made up to Dec 31, 2020

    25 pagesAA

    Confirmation statement made on Sep 03, 2021 with updates

    4 pagesCS01

    Appointment of Mr Kentaro Shirahata as a director on Nov 30, 2020

    2 pagesAP01

    Appointment of Mr Marc Stuart Page as a director on Nov 30, 2020

    2 pagesAP01

    Termination of appointment of Nicholas Hugh Meryon Insall as a director on Nov 30, 2020

    1 pagesTM01

    Termination of appointment of Sarah Lucy Charsley as a director on Nov 30, 2020

    1 pagesTM01

    Full accounts made up to Dec 31, 2019

    25 pagesAA

    Notification of Shire Pharmaceuticals Group as a person with significant control on Sep 15, 2020

    2 pagesPSC02

    Cessation of Takeda Pharmaceutical Company Limited as a person with significant control on Sep 15, 2020

    1 pagesPSC07

    Confirmation statement made on Sep 03, 2020 with updates

    4 pagesCS01

    Secretary's details changed for Shire Corporate Services Limited on Apr 28, 2020

    1 pagesCH04

    legacy

    1 pagesSH20

    Statement of capital on Nov 26, 2019

    • Capital: USD 1
    3 pagesSH19

    legacy

    1 pagesCAP-SS

    Resolutions

    Resolutions
    2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolutions

    Cancellation of share premium account 25/11/2019
    RES13

    Confirmation statement made on Sep 03, 2019 with no updates

    3 pagesCS01

    Full accounts made up to Dec 31, 2018

    24 pagesAA

    Appointment of Mrs Sarah Lucy Charsley as a director on Feb 28, 2019

    2 pagesAP01

    Termination of appointment of Stephen Philip Williams as a director on Feb 08, 2019

    1 pagesTM01

    Who are the officers of SHIRE BIOTECH UK HOLDINGS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    TAKEDA CORPORATE SERVICES LIMITED
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Secretary
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Identification TypeUK Limited Company
    Registration Number11022500
    244206590002
    GRUBIN, Peter Michael
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    EnglandAmerican293835890001
    PAGE, Marc Stuart
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    United KingdomBritish277077440001
    STRAWBRIDGE, Oliver
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Secretary
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    237512690001
    CHARSLEY, Sarah Lucy
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    United KingdomBritish239205090001
    INSALL, Nicholas Hugh Meryon
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    United KingdomBritish248118390001
    SHIRAHATA, Kentaro
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    United KingdomJapanese248114700001
    WEBB, Jonathan Ivan William
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    United KingdomBritish220802930001
    WILLIAMS, Stephen Philip
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Director
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    EnglandBritish232177850001

    Who are the persons with significant control of SHIRE BIOTECH UK HOLDINGS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Shire Pharmaceuticals Group
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    Sep 15, 2020
    Kingdom Street
    W2 6BD London
    1
    United Kingdom
    No
    Legal FormPrivate Limited Company
    Country RegisteredUnited Kingdom
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies Hosue
    Registration Number2883758
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Takeda Pharmaceutical Company Limited
    Doshomachi 4-Chome
    Chuo-Ku
    Osaka
    1-1
    Japan
    Jan 08, 2019
    Doshomachi 4-Chome
    Chuo-Ku
    Osaka
    1-1
    Japan
    Yes
    Legal FormKabushiki Kaisha (Or Stock Company)
    Country RegisteredJapan
    Legal AuthorityEstablished Under The Laws Of Japan
    Place RegisteredRegistered With The Osaka Legal Affairs Bureau #
    Registration Number1200-01-077461
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Shire Plc
    Grenville Street
    JE4 8PX St Helier
    22
    Jersey
    Sep 04, 2017
    Grenville Street
    JE4 8PX St Helier
    22
    Jersey
    Yes
    Legal FormPublic Limited Company
    Country RegisteredJersey
    Legal AuthorityJersey
    Place RegisteredJersey Financail Services Comission
    Registration Number99854
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    Shire Pharmaceuticals International Unlimited Company
    50-58 Baggot Street Lower
    Dublin 2
    Block 2 Miesian Plaza
    Ireland
    Sep 04, 2017
    50-58 Baggot Street Lower
    Dublin 2
    Block 2 Miesian Plaza
    Ireland
    Yes
    Legal FormCorporate
    Country RegisteredIreland
    Legal AuthorityIrish Law
    Place RegisteredCompanies Registration Office In The Republic Of I
    Registration Number534668
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0